Champions Oncology
CSBR
33 hedge funds and large institutions have $32.4M invested in Champions Oncology in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 6 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2.03% less ownership
Funds ownership: 51.36% → 49.33% (-2%)
11% less funds holding
Funds holding: 37 → 33 (-4)
31% less capital invested
Capital invested by funds: $46.7M → $32.4M (-$14.3M)
36% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 11
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAM
Tocqueville Asset Management
New York
|
+$357K |
| 2 |
Wells Fargo
San Francisco,
California
|
+$109K |
| 3 |
OAM
Oberweis Asset Management
Lisle,
Illinois
|
+$40.9K |
| 4 |
Renaissance Technologies
New York
|
+$28.5K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$7.46K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Allianz Asset Management
Munich,
Germany
|
-$508K |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$500K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$445K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$192K |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$179K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $14K | +$5.92K | +912 | +60% |
|
|
VIMU
27
Veritas Investment Management (UK)
London,
United Kingdom
| $12K | – | – | – |
|
|
28
Victory Capital Management
San Antonio,
Texas
| $6K | +$7.46K | +1,150 | New |
|
|
PAM
29
Panagora Asset Management
Boston,
Massachusetts
| $2K | -$23.4K | -3,601 | -89% |
|
|
APC
30
Aspire Private Capital
Cornelius,
North Carolina
| $1K | -$1.44K | -222 | -53% |
|
31
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$493 | +76 | +76% |
|
|
32
Allianz Asset Management
Munich,
Germany
| – | -$508K | -64,904 | Closed |
|
|
33
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$192K | -24,510 | Closed |
|
|
34
Arrowstreet Capital
Boston,
Massachusetts
| – | -$179K | -22,865 | Closed |
|
|
FIA
35
FNY Investment Advisers
New York
| – | -$5K | -672 | Closed |
|
36
UBS Group
Zurich,
Switzerland
| – | -$2K | -225 | Closed |
|
37
Bank of America
Charlotte,
North Carolina
| – | -$1K | -129 | Closed |
|
|
SFS
38
Sowell Financial Services
North Little Rock,
Arkansas
| – | +$195 | +30 | New |
|
CSBR Hedge Fund Activity: Q3 2019 in Review
33 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q3 2019, worth a combined $32.4M — down 31% from $46.7M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of CSBR and 2 opened new positions — a net loss of 4 holders — while 11 trimmed existing stakes and 7 added.
The largest buyer was Tocqueville Asset Management, adding an estimated $357K. The largest seller was Allianz Asset Management, exiting entirely with an estimated $508K sold.
- 33 institutional investors held Champions Oncology (CSBR) as of Q3 2019, down from 37 in Q2 2019.
- Funds reported $32.4M of Champions Oncology stock for Q3 2019, down 31% quarter-over-quarter.
- 2 funds opened new Champions Oncology positions in Q3 2019 and 6 closed out, a net change of -4 holders.
- The largest Champions Oncology buyer in Q3 2019 was Tocqueville Asset Management, an estimated $357K added.
- The largest Champions Oncology seller in Q3 2019 was Allianz Asset Management, an estimated $508K sold.
Based on aggregated 13F filings for Q3 2019.